Showing results (131-140 of 2,231) with videos related to

Sort By:
Pageof 224
Brain Research|December 3, 1990
Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditionsD Arjune, K M Standifer, G W Pasternak, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Pharmacological characterization of nalorphine, a kappa 3 analgesicD Paul, C G Pick, L A Tive, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1989
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metaboliteD Paul, K M Standifer, C E Inturrisi, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changesP J Tiseo, J Cheng, G W Pasternak, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1985
Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazonesE F Hahn, S Nishimura, R R Goodman, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1986
Antagonism of morphine analgesia by intracerebroventricular naloxonazineD A Simone, R J Bodnar, T Portzline, et al.
European Journal of Pharmacology|March 3, 1994
Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptorC C Chien, G Brown, Y X Pan, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1989
Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazoneM A Gistrak, D Paul, E F Hahn, et al.
European Journal of Pharmacology|September 22, 1989
Different mu receptor subtypes mediate spinal and supraspinal analgesia in miceD Paul, R J Bodnar, M A Gistrak, et al.
European Journal of Pharmacology|September 23, 1986
Naloxonazine actions in vivoG S Ling, R Simantov, J A Clark, et al.
Pageof 224